Literature DB >> 23150756

The Many Faces of MDM2 Binding Partners.

Maurisa F Riley1, Guillermina Lozano.   

Abstract

Mdm2 is an essential regulator of the p53 tumor suppressor. Mdm2 is modified at transcriptional, post-transcriptional, and post-translational levels to control p53 activity in normal versus stressed cells. Importantly, errors in these regulatory mechanisms can result in aberrant Mdm2 expression and failure to initiate programmed cell death in response to DNA damage. Such errors can have severe consequences as evidenced by tumor phenotypes resulting from amplification at the Mdm2 locus and changes in post-transcriptional and post-translational regulation of Mdm2. Although Mdm2 mediated inhibition of p53 is well characterized, Mdm2 interacts with many additional proteins and also targets many of these for proteosomal degradation. Mdm2 also has E3-ligase independent functions and p53-independent functions that have important implications for genome stability and cancer.

Entities:  

Keywords:  DNA damage; Mdm2; p53; tumorigenesis; ubiquitination

Year:  2012        PMID: 23150756      PMCID: PMC3494375          DOI: 10.1177/1947601912455322

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  168 in total

1.  The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex.

Authors:  Min Sup Song; Su Jung Song; So Yeon Kim; Hyun Jung Oh; Dae-Sik Lim
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

2.  The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter.

Authors:  T Léveillard; B Wasylyk
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

3.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.

Authors:  L D Mayo; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

4.  Down-regulation of endothelial cell growth inhibitors by enhanced MYCN oncogene expression in human neuroblastoma cells.

Authors:  T Fotsis; S Breit; W Lutz; J Rössler; E Hatzi; M Schwab; L Schweigerer
Journal:  Eur J Biochem       Date:  1999-08

5.  Stimulation of human DNA polymerase epsilon by MDM2.

Authors:  Hitomi Asahara; Ying Li; Jill Fuss; Dale S Haines; Nikolina Vlatkovic; Mark T Boyd; Stuart Linn
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

Review 6.  XIAP as a ubiquitin ligase in cellular signaling.

Authors:  S Galbán; C S Duckett
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

7.  Cyclin G1 associates with MDM2 and regulates accumulation and degradation of p53 protein.

Authors:  Shinya H Kimura; Hiroshi Nojima
Journal:  Genes Cells       Date:  2002-08       Impact factor: 1.891

8.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

9.  Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.

Authors:  Yaara Ofir-Rosenfeld; Kristy Boggs; Dan Michael; Michael B Kastan; Moshe Oren
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

10.  Role of Mdm2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF-2.

Authors:  Susanne Pettersson; Michael Kelleher; Emmanuelle Pion; Maura Wallace; Kathryn L Ball
Journal:  Biochem J       Date:  2009-03-15       Impact factor: 3.857

View more
  37 in total

1.  The MDM2 inducible promoter folds into four-tetrad antiparallel G-quadruplexes targetable to fight malignant liposarcoma.

Authors:  Sara Lago; Matteo Nadai; Emanuela Ruggiero; Martina Tassinari; Maja Marušič; Beatrice Tosoni; Ilaria Frasson; Filippo M Cernilogar; Valentina Pirota; Filippo Doria; Janez Plavec; Gunnar Schotta; Sara N Richter
Journal:  Nucleic Acids Res       Date:  2021-01-25       Impact factor: 16.971

2.  Mdm4 supports DNA replication in a p53-independent fashion.

Authors:  Kai Wohlberedt; Ina Klusmann; Polina K Derevyanko; Kester Henningsen; Josephine Ann Mun Yee Choo; Valentina Manzini; Anna Magerhans; Celeste Giansanti; Christine M Eischen; Aart G Jochemsen; Matthias Dobbelstein
Journal:  Oncogene       Date:  2020-05-19       Impact factor: 9.867

Review 3.  Breaking the Fourth Wall: Modulating Quaternary Associations for Protein Regulation and Drug Discovery.

Authors:  Marcus J C Long; Dziyana Hnedzko; Bo Kyoung Kim; Yimon Aye
Journal:  Chembiochem       Date:  2019-04-01       Impact factor: 3.164

4.  Prognostic value of the PDLIM family in acute myeloid leukemia.

Authors:  Longzhen Cui; Zhiheng Cheng; Kai Hu; Yifan Pang; Yan Liu; Tingting Qian; Liang Quan; Yifeng Dai; Ying Pang; Xu Ye; Jinlong Shi; Lin Fu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

5.  Impact of the Mdm2(SNP309-G) allele on a murine model of colorectal cancer.

Authors:  X Zhang; L Pageon; S M Post
Journal:  Oncogene       Date:  2014-12-01       Impact factor: 9.867

Review 6.  The Mdm network and its regulation of p53 activities: a rheostat of cancer risk.

Authors:  Christine M Eischen; Guillermina Lozano
Journal:  Hum Mutat       Date:  2014-03-06       Impact factor: 4.878

Review 7.  Regulation of MDM2 Stability After DNA Damage.

Authors:  Jiaqi Li; Manabu Kurokawa
Journal:  J Cell Physiol       Date:  2015-10       Impact factor: 6.384

8.  The transcription factor MEF/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism.

Authors:  Mary Ann Suico; Ryosuke Fukuda; Rui Miyakita; Kosuke Koyama; Manabu Taura; Tsuyoshi Shuto; Hirofumi Kai
Journal:  J Biol Chem       Date:  2014-07-31       Impact factor: 5.157

9.  Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer.

Authors:  Maria Rovira-Rigau; Giulia Raimondi; Miguel Ángel Marín; Meritxell Gironella; Ramon Alemany; Cristina Fillat
Journal:  Mol Ther       Date:  2018-09-27       Impact factor: 11.454

Review 10.  Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy.

Authors:  Qin Li; Guillermina Lozano
Journal:  Clin Cancer Res       Date:  2012-12-21       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.